Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

81627Y0875-Purchase of Raboravel V-RG Vaccines

Active
81627Y0875State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The New York City Department of Health and Mental Hygiene (DOHMH) is seeking to establish a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the procurement of RABORAL V-RG coated sachet baits. This licensed oral rabies vaccine is used in the city's baiting program to immunize raccoons and reduce the transmission of rabies to other animals and humans. DOHMH has identified Boehringer Ingelheim as the sole source provider, as they are the only manufacturer and distributor of USDA-approved oral rabies vaccine baits for raccoons and coyotes in the United States. Under the terms of the agreement, the vendor will provide up to 75,600 individual baits per contract year, sold in quantities of 300. Deliveries must be packed with cold packs and shipped to the NYC Public Health Laboratory at 455 First Avenue, New York, NY 10016, with each shipment accompanied by an invoice. Purchase quantities and delivery schedules will be determined by operational needs, including annual fall baiting campaigns, targeted spring baiting, or emergency responses to rabies outbreaks. Interested firms may submit an Expression of Interest via RFI-EPIN 81627Y0875 by November 9, 2026, at 2:00 PM.

General Info

NYC DOHMH will procure oral rabies vaccine baits from Boehringer Ingelheim.

Documents

1

Scope of Work for RFI- 81627Y0875 (Oral Rabies Vaccination)

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNew York → Department Of Health And Mental Hygiene
Contacts1 person available
OfficeNew York, NY, USA
Office AddressNew York, NY, USA
Contacts
Shamecka Williams

Full Description

Show more
Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the NYC Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a six-year agreement with Boehringer Ingelheim Animal Health USA Inc. for the purchase of RABORAL V‑RG®, a licensed Oral Rabies Vaccine (ORV). NYC DOHMH utilizes RABORAL V‑RG® as part of its Oral Rabies Vaccination (ORV) baiting program, which aims to immunize raccoons and reduce the transmission of rabies among raccoons and subsequently to other animals, including dogs, cats and humans in New York City.DOHMH has determined that Boehringer Ingelheim Animal Health USA Inc. is the sole source provider for this product. They are the only manufacturer and distributor of the USDA‑approved oral rabies vaccine baits for use in raccoons and coyotes within the United States. No other company is authorized or licensed to produce or sell an equivalent oral rabies vaccine.Any firm that believes it can legally provide these goods, is invited to submit an Expression of Interest directly to this RFI- EPIN 81627Y0875 no later than 11/9/2026 by 2:00PM.If you need additional assistance with PASSPort, please contact the MOCS Service Desk at https://mocssupport.atlassian.net/servicedesk/customer/portal/8

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

2 days ago

DEADLINE

in 12 days
View Details
NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
Solicitation SPE2DP-26-R-0001 is a sole source, firm-fixed price, indefinite delivery, indefinite quantity contract issued by the Defense Logistics Agency for the procurement of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, in single-dose prefilled syringes. The contract has an eighteen month base term with estimated quantities ranging from a minimum of 277,760 to a maximum of 394,240 units. All products must be FDA approved, serialized according to the Drug Supply Chain Security Act, and manufactured in accordance with Medical Procurement Item Description Number 5. Deliveries are designated as FOB Destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must be completed within 120 days after the date of order. The successful offeror must demonstrate FDA approval or provide a manufacturer commitment letter ensuring supply availability and fixed pricing for the life of the contract. Proposals must be submitted electronically via the DLA Internet Bid Board System by November 6, 2026. Strict adherence to Medical Marking Standard No. 1D is required, specifically regarding cold chain storage between 2 and 8 degrees Celsius and detailed waterproof marking for exterior containers. Contract administration, including payment requests and receiving reports, will be managed through the Wide Area Workflow system. Award will be based on the most advantageous offer considering price, FDA approval, and agreement to all solicitation terms.
Defense Logistics Agency

POSTED

23 days ago

DEADLINE

in 8 days
View Details

More opportunities from New York → Department Of Health And Mental Hygiene

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS